Obidoxime antagonizes the neuromuscular failure induced by neostigmine and diisopropyl fluorophosphate via different mechanisms
- 1 December 1993
- journal article
- research article
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 1 (1) , 19-27
- https://doi.org/10.1007/bf02258336
Abstract
The efficacies and mechanisms of obidoxime in antagonizing the neuromuscular failure induced by neostigmine and diisopropyl fluorophosphate (DFP) were studied in mouse phrenic nerve/diaphragm preparations. Obidoxime antagonized neostigmine-induced tetanic fade (EC50: 300 µM) by inhibiting the regenerative and sustained depolarization during repetitive stimulation. The antagonism was associated with a depression and shortening of single endplate potentials (EPPs) and miniature EPPs (MEPPs). In contrast, the neuromuscular failure induced irreversibly after treatment with DFP and followed by washout was restored by obidoxime at concentrations (EC50: 0.6 µM) 500-fold lower than that against neostigmine. The regenerative depolarization was abolished with no depression of single EPPs and MEPPs, and the antagonistic action persisted after washout of obidoxime. The EC50 of obidoxime was proportionately increased in the presence of increasing concentrations of DFP. Nevertheless, the EC50 against DFP, at a concentration (30 µM) 15-fold in excess of that which caused tetanic fade, was still 10-fold lower than that which antagonized neostigmine. In both cases, the amplitudes of train EPPs were increased. It is concluded that obidoxime antagonizes neostigmine-induced neuromuscular failure by a curare-like action but antagonizes DFP by an enzyme reactivation.Keywords
This publication has 27 references indexed in Scilit:
- Antagonism by tubocurarine and verapamil of the regenerative acetylcholine release from mouse motor nerveEuropean Journal of Pharmacology, 1989
- Reversals of the neostigmine‐induced tetanic fade and endplate potential run‐down with respect to the autoregulation of transmitter releaseBritish Journal of Pharmacology, 1988
- Desensitization of the nicotinic acetylcholine receptor by diisopropylfluorophosphateJournal of Biochemical Toxicology, 1988
- A regenerating release of acetylcholine from mouse motor nerve terminals treated with anticholinesterase agentsNeuroscience Letters, 1986
- Mechanisms of the inhibition by neostigmine of tetanic contraction in the mouse diaphragmBritish Journal of Pharmacology, 1986
- Effects of obidoxime chloride on native and sarin-poisoned frog neuromuscular junctionsPflügers Archiv - European Journal of Physiology, 1984
- Anomalies in theories and therapy of intoxication by potent organophosphorus anticholinesterase compoundsGeneral Pharmacology: The Vascular System, 1982
- Toxicology and pharmacology of bispyridinium oximes insight into the mechanism of action vs Soman poisoning in vivoFundamental and Applied Toxicology, 1981
- Pharmacological actions of HS-6, an oxime, on the neuromuscular junctionEuropean Journal of Pharmacology, 1979
- The reactivating and antidotal actions of n,n'-trimethylenebis (pyridinium-4-aldoxime) (TMB-4) and n,n'-oxydimethylenebis (pyridinum-4-aldoxime) (toxogonin), with particular reference to their effect on phosphorylated acetylcholinesterase in the brainBiochemical Pharmacology, 1966